Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry.


Malavasi V. L. , Vitolo M., Proietti M., Diemberger I., Fauchier L., Marin F., ...More

European journal of clinical investigation, 2022 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2022
  • Doi Number: 10.1111/eci.13773
  • Title of Journal : European journal of clinical investigation
  • Keywords: all-cause death, atrial fibrillation, cancer, malignancy, NOACs, registry, DIRECT ORAL ANTICOAGULANTS, BLEEDING COMPLICATIONS, ACTIVE CANCER, MANAGEMENT, WARFARIN, SAFETY, RISK, THROMBOEMBOLISM, GUIDELINES, EFFICACY

Abstract

Background: The management of patients with atrial fibrillation (AF) and malignancy is challenging given the paucity of evidence supporting their appropriate clinical management.